- South Africa’s nuclear agency, NECSA,has extended the deadline for a request for information (RFI) to replace its ageing 20MW Safari 1 research reactor Pelindaba.
- The submission deadline has been extended from 29 March to 8th April. The state owned entity produces radioisotopes used in diagnostic tests for cancer and heart disease.
- The RFI for the multi-purpose reactor (MPR) to replace its nuclear research reactor was released earlier this month. Read more
NECSA shifted the date stating that suppliers have requested more time to enable them to provide more comprehensive information.
South Africa’s state owned nuclear company responsible for processing source material, including uranium enrichment, and co-operating with other institutions, locally and abroad, on nuclear and related matters for the promotion of socio-economic development in South Africa as well as R&D in the field of nuclear energy and radiation sciences.
The new reactor will help maintain its position as one of the world’s top producers of Molybdenum-99 used in millions of diagnostic tests for cancer, heart disease and other illnesses worldwide.
The 20 MW Safari 1 research reactor is located at Pelindaba and has been in operation since 1965. In 2018, the plant was shut down by the auditor general due to safety concerns. Read more
“The new build reactor will continue with the legacy of producing medical radioisotopes, which are used to treat thousands of patients diagnosed with cancer all over the world,” said Loyiso Tyabashe, group chief executive at NECSA.
Link to tender documents HERE
Author: Bryan Groenendaal
